Johnson & Johnson (JNJ)
273.20
-2.00
(-0.73%)
USD |
NYSE |
Oct 30, 16:00
273.74
+0.54
(+0.20%)
After-Hours: 20:00
Johnson & Johnson Net Income (Quarterly) : 210.00M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 210.00M |
| June 30, 2026 | 5.534B |
| March 31, 2026 | 5.235B |
| December 31, 2025 | 5.116B |
| September 30, 2025 | 5.152B |
| June 30, 2025 | 5.537B |
| March 31, 2025 | 11.00B |
| December 31, 2024 | 3.431B |
| September 30, 2024 | 2.694B |
| June 30, 2024 | 4.686B |
| March 31, 2024 | 3.255B |
| December 31, 2023 | 4.132B |
| September 30, 2023 | 4.309B |
| June 30, 2023 | 5.376B |
| March 31, 2023 | -491.00M |
| December 31, 2022 | 3.227B |
| September 30, 2022 | 4.31B |
| June 30, 2022 | 4.814B |
| March 31, 2022 | 5.149B |
| December 31, 2021 | 4.736B |
| September 30, 2021 | 3.667B |
| June 30, 2021 | 6.278B |
| March 31, 2021 | 6.197B |
| December 31, 2020 | 1.738B |
| September 30, 2020 | 3.554B |
| Date | Value |
|---|---|
| June 30, 2020 | 3.626B |
| March 31, 2020 | 5.796B |
| December 31, 2019 | 4.01B |
| September 30, 2019 | 1.753B |
| June 30, 2019 | 5.607B |
| March 31, 2019 | 3.749B |
| December 31, 2018 | 3.042B |
| September 30, 2018 | 3.934B |
| June 30, 2018 | 3.954B |
| March 31, 2018 | 4.367B |
| December 31, 2017 | -10.71B |
| September 30, 2017 | 3.764B |
| June 30, 2017 | 3.827B |
| March 31, 2017 | 4.422B |
| December 31, 2016 | 3.814B |
| September 30, 2016 | 4.272B |
| June 30, 2016 | 3.997B |
| March 31, 2016 | 4.457B |
| December 31, 2015 | 3.215B |
| September 30, 2015 | 3.358B |
| June 30, 2015 | 4.516B |
| March 31, 2015 | 4.32B |
| December 31, 2014 | 2.521B |
| September 30, 2014 | 4.749B |
| June 30, 2014 | 4.326B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.451B |
| Merck & Co., Inc. | 5.067B |
| Pfizer Inc. | -246.00M |
| Bristol Myers Squibb Co. | 2.162B |
| Abbott Laboratories | 920.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 25.40B |
| Total Expenses (Quarterly) | 25.19B |
| EPS Diluted (Quarterly) | 0.0858 |
| Enterprise Value | 685.05B |
| Gross Profit Margin (Quarterly) | 68.11% |
| Profit Margin (Quarterly) | 0.83% |
| Earnings Yield | 2.41% |
| Operating Earnings Yield | 3.85% |
| Normalized Earnings Yield | 3.394 |